As of November 2024, ImmuPharma has a market cap of $9.29M. This makes ImmuPharma the world's 32940th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $6.73M | -26.56% |
2023 | $9.17M | -9.35% |
2022 | $10.11M | -72.12% |
2021 | $36.28M | -50.56% |
2020 | $73.39M | -16.56% |
2019 | $87.95M | 36.17% |
2018 | $64.59M | -93.09% |
2017 | $934.49M | 226.92% |
2016 | $285.84M | 73.33% |
2015 | $164.91M | -41.18% |
2014 | $280.35M | -19.05% |
2013 | $346.31M | 17.76% |
2012 | $294.09M | -34.46% |
2011 | $448.69M | -6.18% |
2010 | $478.24M | -8.66% |
2009 | $523.59M | 67.11% |
2008 | $313.33M | -18.57% |
2007 | $384.79M | -7.89% |
2006 | $417.77M | 67.03% |
2005 | $250.11M | 7.06% |
2004 | $233.62M | 23.19% |
2003 | $189.65M | - |